针对MDSC-HTR2B来改善乳腺到大脑转移中的免疫检查点抑制剂
bioRxiv : the preprint server for biology
|July 9, 2024
概括
骨髓系衍生抑制细胞 (MDSCs) 通过通过HTR2B抑制T细胞促进乳腺癌大脑转移. 用克洛扎宾和抗PD-1免疫疗法向这种受体显著改善了小鼠的生存率.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 神经科学是一个神经科学.
背景情况:
- 已知骨髓原抑制细胞 (MDSCs) 在乳腺癌中促进瘤生长和免疫逃避.
- 乳腺癌脑转移仍然是一个重大的临床挑战,对潜在机制的理解有限.
- 在乳腺到大脑转移的特定微环境中,MDSCs的作用还不清楚.
研究的目的:
- 调查MDSCs对乳腺至大脑转移性微环境的贡献.
- 确定MDSCs促进大脑转移的分子机制.
- 探索针对转移性乳腺癌中MDSC介导免疫抑制的新型治疗策略.
主要方法:
- 模拟瘤-神经元-免疫微环境的共同培养模型.
- 对患者组织阵列的分析.
- 转移性和内乳腺瘤的活体小鼠模型.
- 用克洛扎宾 (HTR2B抗体) 和抗PD-1免疫疗法进行治疗.
主要成果:
- 在MDSCs上确定了血清受体HTR2B.
- HTR2B信号调节pNF-κB,导致抑制T细胞增殖和增强瘤生长.
- 在小鼠模型中,用克洛扎宾和抗PD-1的联合治疗显著增加了生存率和T细胞透率.
结论:
- MDSC-HTR2B信号传输在乳腺到大脑转移中发挥着关键作用.
- 针对MDSC的HTR2B是一种新的治疗策略.
- 重用神经药物,如克洛扎宾,为转移性乳腺癌患者提供了潜在的立即治疗方法.
相关概念视频
01:27Tumor Immunotherapy
509
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
509
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K